FindTrial
Sign In

RAI-treated Graves' Disease Cohort

Long-term Efficacy and Influencing Factors of Iodine-131 Therapy for Graves' Disease: A Single-Center Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128765
Enrollment
Unknown
Registered
2026-07-25
Start date
2026-07-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves Disease

Interventions

unremitted hyperthyroidism group, normal thyroid function (euthyroid) group, and hypothyroidism group.:N/A

Sponsors

The First Affiliated Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosis of Graves' disease confirmed through clinical evaluation, laboratory tests, and imaging studies; 2.First-time treatment with radioactive iodine; 3.Complete follow-up data: at least one year of follow-up data to assess the time to onset of hypothyroidism.

Exclusion criteria

Exclusion criteria: 1.History of prior external neck irradiation; 2.Presence of other diseases or treatments that may affect the assessment of thyroid function.

Design outcomes

Primary

MeasureTime frame
Long-term Clinical Outcome of Iodine-131 Therapy;—

Countries

China

Contacts

Public ContactXiao Fangsen

The First Affiliated Hospital of Xiamen University

xfs888@163.com+86 592 2137710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026